Dr Muhammad Adnan Khattak (Medical Oncologist)
- Name
- Dr Muhammad Adnan Khattak
- Qualifications
- FRACP 2012
- MBBS 2001
- Occupation
- Medical Oncologist
- Gender
- Male
- Medical Specialties
- General Practice
Clinical Professor Adnan Khattak is a Medical Oncologist with special interest in gastrointestinal / hepatobiliary cancers, melanoma and lung cancer. In addition to his private practice, he works as a Consultant Medical Oncologist at Fiona Stanley Hospital (FSH) where he is also the Medical Oncology Clinical Trials Lead.
Dr Khattak did his initial specialist training at The Queen Elizabeth Hospital and Flinders Medical Centre in Adelaide before going to the UK. He worked as a Clinical Research Fellow in the melanoma unit at the Royal Marsden Hospital in London. He received his Fellowship in Medical Oncology in 2013 and started working as a Consultant at Royal Perth Hospital before transitioning to FSH in 2015.
Dr Khattak is an active researcher, with interests in colorectal cancer, melanoma and cancer immunotherapy. He is the Medical Oncology Clinical Trials Lead at Fiona Stanley Hospital and the Primary Investigator of many Phase 1, 2 & 3 International Clinical Trials. He is the pioneer of early drug development (Phase 1) work at Fiona Stanley Hospital and now leads the largest trials unit in Perth South Metro.
He has more than 40 publications at this stage in various peer-reviewed journals including the New England Journal of Medicine, the Lancet Oncology, Journal of Clinical Oncology and European Journal of Cancer. He has also co-authored the National Health & Medical Research Council (NHMRC) guidelines for the management of advanced colorectal cancer (2017).
He has presented his research at a number of National and International scientific meetings. He has been invited as an International visiting speaker to Hong Kong, Taiwan, Saudi Arabia, China, Singapore and India. His current research projects include blood-based biomarkers (circulating tumour cells and circulating tumour DNA) of response & resistance to immunotherapy in cancer (lung, GI & melanoma). He is also leading an early stage bowel cancer translational research project (Notch pathway) aimed at identifying patients at high risk of disease relapse and those that are less likely to benefit from post-operative chemotherapy.
- Hospital Affiliations
- St John of God Murdoch Hospital
- St John of God Subiaco Hospital
- Affiliated Clinics
- Icon Cancer Centre Rockingham
- Western Oncology Subiaco
Practice Locations
Perth
- Icon Cancer Centre Rockingham
- Address
- 2 Civic Boulevard
Rockingham WA 6168
Australia
- Phone
- 08 9500 7800
- Fax
- 08 8490 2305
- Western Oncology Subiaco
- Address
- North One Building
Suite 106 9 Salvado Road
Subiaco WA 6008
Australia
- Phone
- 08 6102 3640
